ReShape Lifesciences Inc. Profile Avatar - Palmy Investing

ReShape Lifesciences Inc.

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band Syst…

Medical - Devices
US, San Clemente [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

ReShape Lifesciences Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of RSLS's Analysis
CIK: - CUSIP: 761123603 ISIN: US76090R2004 LEI: - UEI: -
Secondary Listings
RSLS has no secondary listings inside our databases.